NovaBay Pharmaceuticals Inc.

(NYSE:NBY)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops, manufactures, and markets anti-infective products for a multitude of uses. It is predominantly focused on commercializing prescription Avenova for the domestic eye care market in the United States. Avenova is the only eye care product formulated with proprietary, stable and pure form of hypochlorous acid (marketed as Neutrox). The company develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. It has partnerships for NeutroPhase in the United States, as well as in other markets.

Contact Information

Website: www.novabay.com
Email: jhall@novabay.com
Main Phone: +1 510 899-8800
Address: 2000 Powell Street
Address 2: Suite 1150
State: CA
City / Town: Emeryville
Country: US
Postal Code: 94608

Issuer Information

Exchange: AMX
CEO: Justin M. Hall
Employees: 25
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A